CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in ALMS — Alumis Inc.

CIK 884546 SAN FRANCISCO, CA

Position in ALMS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$19,701,770

+$5,704,151 QoQ

Shares Held

700,134

+10.2% QoQ

Ownership

0.541%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#32

of 198 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. ALMS ranks #72 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,041,282	$1,013,966,007
2	REGN	Regeneron Pharmaceuticals, Inc.	846,306	$527,705,642
3	RVMD	Revolution Medicines, Inc.	1,917,025	$359,020,441
4	MRNA	Moderna, Inc.	4,838,884	$338,867,045
5	ALNY	Alnylam Pharmaceuticals, Inc.	755,377	$227,391,137
6	INCY	Incyte Corp	1,692,439	$191,854,884
7	RPRX	Royalty Pharma plc	3,083,528	$172,893,414
8	CYTK	Cytokinetics Inc	1,565,781	$133,388,883

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$19,701,770	700,134	+10.2%	Shares	Sole	2026-08-14
2026-03-31	$13,997,619	635,389	+26.1%	Shares	Sole	2026-05-15
2025-12-31	$4,919,772	504,075	+2.7%	Shares	Sole	2026-02-13
2025-09-30	$1,959,097	491,002	+29.6%	Shares	Sole	2025-11-10
2025-06-30	$1,136,550	378,850	+196.3%	Shares	Sole	2025-08-12
2025-03-31	$785,023	127,854	+12.7%	Shares	Sole	2025-09-15
2024-12-31	$891,331	113,401	+4.4%	Shares	Sole	2025-02-06
2024-09-30	$1,159,773	108,593	—	Shares	Sole	2024-11-12
No filing history on record for this holder in this stock.